Crystallization (Comment) | Organism |
---|---|
structure of 3CLpro in complex with compound 2-[4-(chloroacetyl)-2-oxo-1,2,5,6-tetrahydropyridin-3-yl]-N-(3-chlorophenyl)acetamide. The predicted warhead of the compound binds covalently to the catalytic residue C145, and there are interactions of the compound with S1' and S2 subsites at the ligand binding pocket | Severe acute respiratory syndrome coronavirus 2 |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
2-[3-[(2Z)-3-(2H-1,3-benzodioxol-5-yl)prop-2-enoyl]-3-hydroxy-2-oxo-2,3-dihydro-1H-indol-1-yl]acetamide | - |
Severe acute respiratory syndrome coronavirus 2 | |
2-[4-(chloroacetyl)-2-oxo-1,2,5,6-tetrahydropyridin-3-yl]-N-(3-chlorophenyl)acetamide | - |
Severe acute respiratory syndrome coronavirus 2 | |
5-bromo-2-[(2Z)-2-[5-cyano-1-(3-hydroxypropyl)-4-methyl-2,6-dioxo-1,6-dihydropyridin-3(2H)-ylidene]hydrazinyl]benzoic acid | - |
Severe acute respiratory syndrome coronavirus 2 |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Severe acute respiratory syndrome coronavirus 2 | P0DTD1 | replicase polyprotein 1ab | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
MCA-AVLQSGFR-Lys(Dnp)-Lys-NH2 + H2O | - |
Severe acute respiratory syndrome coronavirus 2 | MCA-AVLQ + SGFR-Lys(Dnp)-Lys-NH2 | - |
? |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.0085 | - |
pH 7.3, temperature not specified in the publication | Severe acute respiratory syndrome coronavirus 2 | 2-[4-(chloroacetyl)-2-oxo-1,2,5,6-tetrahydropyridin-3-yl]-N-(3-chlorophenyl)acetamide | |
0.0191 | - |
pH 7.3, temperature not specified in the publication | Severe acute respiratory syndrome coronavirus 2 | 5-bromo-2-[(2Z)-2-[5-cyano-1-(3-hydroxypropyl)-4-methyl-2,6-dioxo-1,6-dihydropyridin-3(2H)-ylidene]hydrazinyl]benzoic acid | |
0.0361 | - |
pH 7.3, temperature not specified in the publication | Severe acute respiratory syndrome coronavirus 2 | 2-[3-[(2Z)-3-(2H-1,3-benzodioxol-5-yl)prop-2-enoyl]-3-hydroxy-2-oxo-2,3-dihydro-1H-indol-1-yl]acetamide |